- Home
- ALNY vs RDDT Comparison
ALNY vs RDDT Comparison
Compare ALNY & RDDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALNY
- RDDT
- Stock Information
- Founded
- ALNY 2002
- RDDT 2005
- Country
- ALNY United States
- RDDT United States
- Employees
- ALNY N/A
- RDDT N/A
- Industry
- ALNY Biotechnology: Pharmaceutical Preparations
- RDDT
- Sector
- ALNY Health Care
- RDDT
- Exchange
- ALNY Nasdaq
- RDDT NYSE
- Market Cap
- ALNY 33.2B
- RDDT 30.0B
- IPO Year
- ALNY 2004
- RDDT 2024
- Fundamental
- Price
- ALNY $264.99
- RDDT $188.53
- Analyst Decision
- ALNY Buy
- RDDT Buy
- Analyst Count
- ALNY 24
- RDDT 21
- Target Price
- ALNY $299.09
- RDDT $150.90
- AVG Volume (30 Days)
- ALNY 643.5K
- RDDT 4.7M
- Earning Date
- ALNY 02-13-2025
- RDDT 02-12-2025
- Dividend Yield
- ALNY N/A
- RDDT N/A
- EPS Growth
- ALNY N/A
- RDDT N/A
- EPS
- ALNY N/A
- RDDT N/A
- Revenue
- ALNY $2,094,795,000.00
- RDDT $1,122,248,000.00
- Revenue This Year
- ALNY $24.87
- RDDT $61.93
- Revenue Next Year
- ALNY $18.53
- RDDT $33.10
- P/E Ratio
- ALNY N/A
- RDDT N/A
- Revenue Growth
- ALNY 21.54
- RDDT 48.70
- 52 Week Low
- ALNY $141.98
- RDDT $37.35
- 52 Week High
- ALNY $304.39
- RDDT $191.00
- Technical
- Relative Strength Index (RSI)
- ALNY 61.89
- RDDT N/A
- Support Level
- ALNY $245.69
- RDDT N/A
- Resistance Level
- ALNY $256.93
- RDDT N/A
- Average True Range (ATR)
- ALNY 9.38
- RDDT 0.00
- MACD
- ALNY 2.95
- RDDT 0.00
- Stochastic Oscillator
- ALNY 99.91
- RDDT 0.00
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
About RDDT REDDIT INC
Reddit Inc is engaged in providing internet content. The company provides online services that include gaming, sports, business, crypto, television and others.